These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7535271)

  • 1. [Effect of the neuropeptide substance P on the activity of the brain dopaminergic system in experimental parkinsonism].
    Krasnova NN; Bychkov ER; Dambinova SA
    Fiziol Cheloveka; 1995; 21(1):30-7. PubMed ID: 7535271
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
    Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV
    Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
    [No Abstract]   [Full Text] [Related]  

  • 3. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
    Mura A; Feldon J; Mintz M
    Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.
    Lopez-Real A; Rey P; Soto-Otero R; Mendez-Alvarez E; Labandeira-Garcia JL
    J Neurosci Res; 2005 Sep; 81(6):865-73. PubMed ID: 16015598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of intranasally administered substance P in parkinsonian syndrome].
    Kryzhanovskiĭ GN; Kucherianu VG; Godlevskiĭ LS; Mazarati AD
    Biull Eksp Biol Med; 1992 Jan; 113(1):16-9. PubMed ID: 1382692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the probenecid test for the diagnosis and treatment of Parkinsonism. Review of the literature and personal experience (author's transl)].
    Vanderheyden JE; Dekoninck WJ; Lefèvre A; Mendlewicz J
    Encephale; 1980; 6(4):349-66. PubMed ID: 6160034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Kucherianu VG; Kudrin VS; Zhigal'tsev IV; Nikushkin EV; Sandalov IuG; Kaplun AP; Shvets VI
    Biull Eksp Biol Med; 1997 Feb; 123(2):150-3. PubMed ID: 9280483
    [No Abstract]   [Full Text] [Related]  

  • 10. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time dynamics of dopamine released from neuronal transplants in experimental Parkinson's disease.
    Cragg SJ; Clarke DJ; Greenfield SA
    Exp Neurol; 2000 Jul; 164(1):145-53. PubMed ID: 10877925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
    Boireau A; Miquet JM; Dubédat P; Meunier M; Doble A
    Neuroreport; 1994 Oct; 5(16):2157-60. PubMed ID: 7865766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
    Pifl C; Giros B; Caron MG
    Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
    [No Abstract]   [Full Text] [Related]  

  • 14. [Participation of galaninergic brain structures in response to the systemic lipopolysaccharide administration].
    Klimenko VM; Liudyno VI; Langel U; Krasnova IN; Abdurasulova IN
    Biull Eksp Biol Med; 1998 Apr; 125(4):430-3. PubMed ID: 9631729
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of liposomal form of L-Dopa on the level of dopamine, its metabolites, and phospholipid metabolism in the striatum of mice with experimental parkinsonian syndrome].
    Iurasov VV; Podgornyĭ GI; Kucherianu VG; Kudrin VS; Nikushkin EV; Zhigal'tsev IV; Sandalov IuG; Kaplun AP; Shvets VI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1996 Dec; 122(12):614-7. PubMed ID: 9280455
    [No Abstract]   [Full Text] [Related]  

  • 16. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
    Konstandi M; Harkitis P; Thermos K; Ogren SO; Johnson EO; Tzimas P; Marselos M
    Neurotoxicology; 2007 Jul; 28(4):860-7. PubMed ID: 17570529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with 1,2,3,4-tetrahydroisoquinolone affects the levels of nitric oxide, S-nitrosothiols, glutathione and the enzymatic activity of gamma-glutamyl transpeptidase in the dopaminergic structures of rat brain.
    Lorenc-Koci E; Sokołowska M; Kwiecień I; Włodek L
    Brain Res; 2005 Jul; 1049(2):133-46. PubMed ID: 15946655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism.
    Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP
    Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Parkinson syndrome].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111. PubMed ID: 4773983
    [No Abstract]   [Full Text] [Related]  

  • 20. Injection of the neuropeptide CNP into dopaminergic rat brain areas decreases alcohol intake.
    Romieu P; Gobaille S; Aunis D; Zwiller J
    Ann N Y Acad Sci; 2008 Oct; 1139():27-33. PubMed ID: 18991845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.